Remschmidt H E, Schulz E, Martin M, Warnke A, Trott G E
Dept. of Child and Adolescent Psychiatry, Philipps-University, Marburg, Germany.
Schizophr Bull. 1994;20(4):727-45. doi: 10.1093/schbul/20.4.727.
Schizophrenic disorders in childhood are rare: 0.1-1 percent of all schizophrenic disorders manifest themselves before age 10, and 4 percent before age 15. There is, however, a remarkable increase in schizophrenia during adolescence. Age and developmental stage also influence symptoms, course, and outcome. The evidence for a male preponderance in the very early-onset group (< 14) does not apply for adolescents over age 14. The presence of positive and negative precursor symptoms can be demonstrated in child and adolescent schizophrenia before the first clinical manifestation leading to inpatient treatment. With regard to pharmacologic treatment, atypical neuroleptics such as clozapine can be used successfully. As to outcome, schizophrenic psychoses with early manifestation have a poor prognosis. The patients' premorbid personality also seems to be of great importance: A poor prognosis can be found in patients who were cognitively impaired, shy, introverted, and withdrawn before the beginning of their psychotic state.
所有精神分裂症障碍中,0.1% - 1%在10岁前发病,4%在15岁前发病。然而,青春期精神分裂症发病率显著上升。年龄和发育阶段也会影响症状、病程及预后。极早发组(< 14岁)男性占优势这一证据并不适用于14岁以上的青少年。在首次出现导致住院治疗的临床表现之前,儿童和青少年精神分裂症患者可出现阳性和阴性前驱症状。在药物治疗方面,氯氮平之类的非典型抗精神病药物可成功使用。至于预后,早发的精神分裂症性精神病预后较差。患者病前人格似乎也很重要:在精神状态开始之前就存在认知障碍、害羞、内向及孤僻的患者预后较差。